, WHO Expert Committee on Drug Dependence: Twenty-first report., 1978.
WHO Expert Committee on Drug Dependence: Twenty-first report., 1978. ,
New Targets and Inhibitors of Mycobacterial Sulfur Metabolism, Infectious Disorders - Drug Targets, vol.13, issue.2, pp.85-115, 2013. ,
Detection of Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis Isolates from China, Journal of Clinical Microbiology, vol.43, issue.11, pp.5477-5482, 2005. ,
Novel Compounds and Drugs and Recent Patents in Treating Multidrug- Resistant and Extensively Drug-Resistant Tuberculosis, Recent Patents on Anti-Infective Drug Discovery, vol.7, issue.2, pp.141-156, 2012. ,
Mycobacterial DNA Replication as a Target for Antituberculosis Drug Discovery, Current Topics in Medicinal Chemistry, vol.17, issue.19, pp.2129-2142, 2017. ,
New agents for the treatment of drug-resistant Mycobacterium tuberculosis, Advanced Drug Delivery Reviews, vol.102, pp.55-72, 2016. ,
Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis, Tuberculosis, vol.83, issue.1-3, pp.91-97, 2003. ,
The Envelope of Mycobacteria, Annual Review of Biochemistry, vol.64, issue.1, pp.29-63, 1995. ,
The Envelope Layers of Mycobacteria with Reference to their Pathogenicity, Advances in Microbial Physiology, vol.39, pp.131-203, 1997. ,
The outer parts of the mycobacterial envelope as permeability barriers, Frontiers in Bioscience, vol.3, issue.4, pp.d1253-1261, 1998. ,
Ligation of arabinogalactan to peptidoglycan in the cell wall of Mycobacterium smegmatis requires concomitant synthesis of the two wall polymers, Microbiology, vol.148, issue.10, pp.3059-3067, 2002. ,
The Molecular Genetics of Mycolic Acid Biosynthesis, Microbiology Spectrum, vol.2, issue.4, pp.2-0003, 2014. ,
The Mechanism of Isoniazid Killing: Clarity Through the Scope of Genetics, Annual Review of Microbiology, vol.61, issue.1, pp.35-50, 2007. ,
Biogenesis of the mycobacterial cell wall and the site of action of ethambutol, Antimicrobial Agents and Chemotherapy, vol.39, issue.11, pp.2484-2489, 1995. ,
Delamanid: A new armor in combating drug-resistant tuberculosis, Journal of Pharmacology and Pharmacotherapeutics, vol.5, issue.3, p.222, 2014. ,
OPC-67683, a Nitro-Dihydro-Imidazooxazole Derivative with Promising Action against Tuberculosis In Vitro and In Mice, PLoS Medicine, vol.3, issue.11, p.e466, 2006. ,
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis, New England Journal of Medicine, vol.366, issue.23, pp.2151-2160, 2012. ,
PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release, Science, vol.322, issue.5906, pp.1392-1395, 2008. ,
Synthesis, Antitubercular Activity and Mechanism of Resistance of Highly Effective Thiacetazone Analogues, PLoS ONE, vol.8, issue.1, p.e53162, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02281784
Advances in Drug Discovery and Development for Pediatric Tuberculosis, Mini-Reviews in Medicinal Chemistry, vol.16, issue.6, pp.481-497, 2016. ,
Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane, Nature Chemical Biology, vol.8, issue.4, pp.334-341, 2012. ,
MmpL Genes Are Associated with Mycolic Acid Metabolism in Mycobacteria and Corynebacteria, Chemistry & Biology, vol.19, issue.4, pp.498-506, 2012. ,
Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases, Journal of Medicinal Chemistry, vol.57, issue.7, pp.3126-3139, 2014. ,
Improved BM212 MmpL3 Inhibitor Analogue Shows Efficacy in Acute Murine Model of Tuberculosis Infection, PLoS ONE, vol.8, issue.2, p.e56980, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01054300
Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis, Antimicrobial Agents and Chemotherapy, vol.58, issue.11, pp.6413-6423, 2014. ,
Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis, Science Translational Medicine, vol.5, issue.214, pp.214ra168-214ra168, 2013. ,
Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action, Future Microbiology, vol.7, issue.7, pp.823-837, 2012. ,
New Derivatives of BM212: A Class of Antimycobacterial Compounds Based on the Pyrrole Ring as a Scaffold, Mini-Reviews in Medicinal Chemistry, vol.7, issue.1, pp.65-78, 2007. ,
Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis, ChemMedChem, vol.8, issue.2, pp.313-321, 2013. ,
Synthesis of novel 3-cyclohexylpropanoic acid-derived nitrogen heterocyclic compounds and their evaluation for tuberculostatic activity, Bioorganic & Medicinal Chemistry, vol.20, issue.1, pp.137-144, 2012. ,
Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues, European Journal of Medicinal Chemistry, vol.89, pp.13-20, 2015. ,
Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis, Nature Genetics, vol.45, issue.7, pp.784-790, 2013. ,
Determining Mutation Rates in Bacterial Populations, Methods, vol.20, issue.1, pp.4-17, 2000. ,
MmpL3 is the flippase for mycolic acids in mycobacteria, Proceedings of the National Academy of Sciences, vol.114, issue.30, pp.7993-7998, 2017. ,
MmpL transporter-mediated export of cell-wall associated lipids and siderophores in mycobacteria, Tuberculosis, vol.100, pp.32-45, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02391838
The diverse family of MmpL transporters in mycobacteria: from regulation to antimicrobial developments, Molecular Microbiology, vol.104, issue.6, pp.889-904, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02137585
SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis, Antimicrobial Agents and Chemotherapy, vol.56, issue.4, pp.1797-1809, 2012. ,
Structure?Function Profile of MmpL3, the Essential Mycolic Acid Transporter from Mycobacterium tuberculosis, ACS Infectious Diseases, vol.2, issue.10, pp.702-713, 2016. ,
Designer Arrays for Defined Mutant Analysis To Detect Genes Essential for Survival of Mycobacterium tuberculosis in Mouse Lungs, Infection and Immunity, vol.73, issue.4, pp.2533-2540, 2005. ,
High-Resolution Phenotypic Profiling Defines Genes Essential for Mycobacterial Growth and Cholesterol Catabolism, PLoS Pathogens, vol.7, issue.9, p.e1002251, 2011. ,
Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3, Antimicrobial Agents and Chemotherapy, vol.60, issue.9, pp.5198-5207, 2016. ,
Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression, Scientific Reports, vol.7, issue.1, 2017. ,
Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform, Nature Microbiology, vol.2, issue.4, p.16274, 2017. ,
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212, Antimicrob Agents Chemother, vol.56, pp.324-331, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00968568
Identification of Novel Inhibitors ofM. tuberculosisGrowth Using Whole Cell Based High-Throughput Screening, ACS Chemical Biology, vol.7, issue.8, pp.1377-1384, 2012. ,
Indoleamides are active against drug-resistant Mycobacterium tuberculosis, Nature Communications, vol.4, issue.1, p.2907, 2013. ,
Novel Acetamide Indirectly Targets Mycobacterial Transporter MmpL3 by Proton Motive Force Disruption, Frontiers in Microbiology, vol.9, p.2960, 2018. ,
Discovery of benzothiazole amides as potent antimycobacterial agents, Bioorganic & Medicinal Chemistry Letters, vol.28, issue.19, pp.3177-3181, 2018. ,
HC2091 KillsMycobacterium tuberculosisby Targeting the MmpL3 Mycolic Acid Transporter, Antimicrobial Agents and Chemotherapy, vol.62, issue.7, pp.e02459-17, 2018. ,
A new piperidinol derivative targeting mycolic acid transport in Mycobacterium abscessus, Mol Microbiol, vol.101, pp.515-529, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02137602
Diphenylether-Modified 1,2-Diamines with Improved Drug Properties for Development against Mycobacterium tuberculosis, ACS Infectious Diseases, vol.2, issue.7, pp.500-508, 2016. ,
Antiinfectives targeting enzymes and the proton motive force, Proceedings of the National Academy of Sciences, vol.112, issue.51, pp.E7073-E7082, 2015. ,
Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds In Vitro, Antimicrobial Agents and Chemotherapy, vol.61, issue.4, pp.2399-2415, 2017. ,
Oxa, Thia, Heterocycle, and Carborane Analogues of SQ109: Bacterial and Protozoal Cell Growth Inhibitors, ACS Infectious Diseases, vol.1, issue.5, pp.215-221, 2015. ,
In Vitro Characterization of the Anti-Bacterial Activity of SQ109 against Helicobacter pylori, PLoS ONE, vol.8, issue.7, p.e68917, 2013. ,
Importance of the thiomorpholine introduction in new pyrrole derivatives as antimycobacterial agents analogues of BM 212, Bioorganic & Medicinal Chemistry, vol.11, issue.4, pp.515-520, 2003. ,
Novel 2-(2-phenalkyl)-1H-benzo[d]imidazoles as antitubercular agents. Synthesis, biological evaluation and structure?activity relationship, Bioorganic & Medicinal Chemistry, vol.23, issue.9, pp.2112-2120, 2015. ,
Insights into the smooth-to-rough transitioning inMycobacterium bolletiiunravels a functional Tyr residue conserved in all mycobacterial MmpL family members, Molecular Microbiology, vol.99, issue.5, pp.866-883, 2015. ,
Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target, Cell, vol.176, issue.3, pp.636-648.e13, 2019. ,
Mycobacterium tuberculosis ?RD1 ?panCD: A safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis, Vaccine, vol.24, issue.37-39, pp.6309-6320, 2006. ,
An Overview of the Clinical and Laboratory Standards Institute (CLSI) and Its Impact on Antimicrobial Susceptibility Tests, Antimicrobial Susceptibility Testing Protocols, pp.1-6, 2007. ,
Molecular cloning: a laboratory manual, 2001. ,
Evaluation of the Mycobactericidal Effect of Thio-functionalized Carbohydrate Derivatives, Molecules, vol.22, issue.5, p.812, 2017. ,
Deletion of a dehydratase important for intracellular growth and cording renders roughMycobacterium abscessusavirulent, Proceedings of the National Academy of Sciences, vol.113, issue.29, pp.E4228-E4237, 2016. ,
Temperature-induced changes in the cell-wall components of Mycobacterium thermoresistibile, Microbiology, vol.148, issue.10, pp.3145-3154, 2002. ,
SWISS-MODEL: homology modelling of protein structures and complexes, Nucleic Acids Research, vol.46, issue.W1, pp.W296-W303, 2018. ,